多焦点人工晶状体植入术后的临床观察.docVIP

多焦点人工晶状体植入术后的临床观察 　　[摘要] 目的 探讨该院白内障超声乳化联合Acrysof Restor+3D （SN6AD1） 多焦点人工晶状体植入的术后疗效。方法 整群选取该院2013年1月―2014年12月93例（128眼）老年性白内障患者，行白内障超声乳化术，分为试验组（多焦组）64眼植入多焦点人工晶状体Acrysof Restor+3D （SN6AD1），对照组（单焦组）64眼植入单焦点人工晶状体Acrysof IQ（SN60WF），对术后视力及疗效进行分析。 结果 128眼手术均顺利，术后1周裸眼远视力多焦组（4.93±0.08），单焦组（4.96±0.05），两组比较差异无统计学意义（P?0.05）；裸眼近视力多焦组（4.85±0.08），单焦组（4.32±0.06），多焦组优于单焦组，差异有统计学意义（P?0.05）。无严重局部及全身并发症发生。结论 白内障超声乳化联合多焦点人工晶状体植入术效果显著，具有切口小，恢复快，良好的术后远视力及近视力，患者满意度高，可以适合于白内障术后不愿意配戴老花镜的患者。 　　[关键词] 白内障；多焦点人工晶状体；超声乳化 　　[中图分类号] R77 [文献标识码] A [文章编号] 1674-0742（2015）08（b）-0004-03 　　[Abstract] Objective To investigate the clinical effect of phacoemulsification cataract surgery combined with Acrysoft Restor+3D （SN6AD1） multifocal intraocular lens （MIOL） implantation underwent in our hospital. Methods 93 elderly patients with cataract（128 eyes） underwent phacoemulsification cataract surgery in our hospital from January， 2013 to December， 2014 were enrolled in this study. They were divided into two groups. Patients in trial group （MIOL group， 64 eyes） were implanted MIOL Acrysof Restor+3D （SN6AD1） during surgery， and single focus intraocular lens Acrysof IQ （SN60WF） were used for patients in control group （single focal group， 64 eyes）. The data of visual acuity and effect after surgery of the two groups were analyzed. Results All of the 128 surgeries were completed successfully. One week after surgery， the naked visual acuity of MIOL group was （4.93±0.08）， and that of the control group was （4.96±0.0.05）. There was no significant difference between the two groups（P0.05）. While for naked near visual acuity， it was （4.85±0.08） in the trial group and （4.32±0.06） in the control group. There was significant difference between the two groups（P0.05）. No serious ocular and general complications happened during and after the surgery. Conclusion Phacoemulsification cataract surgery combined with MIOL implantation has significant effect on elderly cataract patients with rapider visual acuity recovery and